Furthermore, a reduction of HMGA2 levels in NPC43 cell-derived exosomes significantly impaired the association of exosome treatment with vascular permeability, with a 50% reduction in passage of the fluorescent probes and a 75% reduction in invading cancer cells compared to those observed after treatment with exosomes derived from control cells. This evidence concerns the gene HMGA2 and cancer.